Viewing Study NCT00299520


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT00299520
Status: COMPLETED
Last Update Posted: 2008-04-04
First Post: 2006-03-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)
Sponsor: Arpida AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module